Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Integral Diagnostics Ltd. ( (AU:IDX) ) has issued an update.
Integral Diagnostics Ltd., an ASX-listed provider of diagnostic imaging services under ticker IDX, continues to position itself as a stable healthcare services company offering income returns to shareholders through dividends on its ordinary fully paid shares. The company has declared an interim dividend of AUD 0.033 per ordinary share for the six months ended 31 December 2025, with an ex-dividend date of 4 March 2026, a record date of 5 March 2026, and payment scheduled for 2 April 2026, signalling ongoing commitment to shareholder distributions and providing clarity on the near-term cash return timetable.
The most recent analyst rating on (AU:IDX) stock is a Hold with a A$2.50 price target. To see the full list of analyst forecasts on Integral Diagnostics Ltd. stock, see the AU:IDX Stock Forecast page.
More about Integral Diagnostics Ltd.
Integral Diagnostics Ltd. operates diagnostic imaging services, providing radiology and related medical imaging to healthcare providers and patients. The company is listed on the ASX under the code IDX and pays regular dividends on its ordinary fully paid shares, reflecting its profile as an income-generating healthcare services business.
Average Trading Volume: 583,697
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$905.7M
For detailed information about IDX stock, go to TipRanks’ Stock Analysis page.